c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma
YAN-HUI WU(Huazhong University of Science and Technology), Xiao‐Ping Chen(University of Washington)
Cited by 13
Related Papers
Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study
|Journal of Hepatology|2016|385